-
Posted by
Two Blokes Apr 18 -
Filed in
Stock
-
2 views
Northrop Grumman's $91.5B backlog (+9% YoY) is driven by B-21, E-130J, and NATO demand offers strong 2025 revenue visibility despite modest 3% sales growth. Trading at 19x forward EPS vs. 5Y avg of 17.5x; base-case PT of $585 reflects 8% upside on $28.55 EPS amid macro tailwinds. DOGE-driven budget risks, drone/AI disruptors like Anduril, and reliance on U.S. contracts (~85% revenue) temper alpha expectations.
